These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 3698462)
21. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Sum CY; Yacobi A; Kartzinel R; Stampfli H; Davis CS; Lai CM Clin Pharmacol Ther; 1983 Oct; 34(4):427-34. PubMed ID: 6617063 [TBL] [Abstract][Full Text] [Related]
22. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentration. Cheymol G; Jaillon P; Lecoq B; Lecoq V; Cheymol A; Krumenacker M J Cardiovasc Pharmacol; 1987 Jun; 9(6):694-8. PubMed ID: 2442536 [TBL] [Abstract][Full Text] [Related]
24. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988 [TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics and onset of action of esmolol in anesthetized dogs. Quon CY; Gorczynski RJ J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328 [TBL] [Abstract][Full Text] [Related]
27. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent. Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005 [TBL] [Abstract][Full Text] [Related]
28. [Effects in humans of a new beta adrenergic receptor blocking agent on tachycardia induced with isoprenaline]. Fuccella LM; Bianchi-Porro G; Foresti A; Mandelli V Minerva Cardioangiol; 1973 Dec; 21(12):854-9. PubMed ID: 4149917 [No Abstract] [Full Text] [Related]
29. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. von Bahr C; Collste P; Frisk-Holmberg M; Haglund K; Jorfelt L; Orme M; Ostman J; Sjoqvist F Clin Pharmacol Ther; 1976 Aug; 20(2):130-7. PubMed ID: 7373 [TBL] [Abstract][Full Text] [Related]
30. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol. Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902 [TBL] [Abstract][Full Text] [Related]
31. Pafenolol, a new beta 1-selective blocking agent, in mild hypertension. Result of an inpatient study and a subsequent outpatient follow-up. Sigurdsson JA; Bengtsson C; Bjurö T Eur J Clin Pharmacol; 1984; 26(5):549-53. PubMed ID: 6147255 [TBL] [Abstract][Full Text] [Related]
32. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955 [TBL] [Abstract][Full Text] [Related]
33. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade. Hansen O; Johansson BW; Nilsson-Ehle P Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731 [TBL] [Abstract][Full Text] [Related]